Dr Jim Kovach, SVP Business Development
USA 2015 Presentation - CrowdOptic Inc.*
USA 2015 Audio Presentation - CrowdOptic Inc.*
If you already have access, please [Login]
Access is available via an IDTechEx Market Intelligence Subscription
CrowdOptic's middlewear for wearables allows enterprises to manage wearable devices in the field from a single platform. CrowdOptic's enterprise console and device-side connectors enable a range of wearable computing applications, from livestreaming to context-aware computing. Smartglass use cases of Google Glass and Sony SmartEyeglass will be discussed for CrowdOptic clients in sports, medical devices, and field services.
講演者の経歴 (Jim Kovach)
James Kovach, MD, JD, serves as Senior Vice President of Business Development for CrowdOptic, a venture-backed company using real-time sensor data from electronic devices and its own patented CrowdOptic algorithms to identify and track where devices are aimed (focus) and to identify groups of people with the same focus (clusters). Dr. Kovach received his medical degree with distinction from the University of Kentucky while simultaneously playing in the National Football League. Following his NFL career, he attended law school at Stanford University and practiced corporate law in Palo Alto California.
会社紹介 (CrowdOptic Inc.)
View CrowdOptic Inc. Timeline
CrowdOptic develops middleware for wearables that allows enterprises to manage wearable computing devices in the field from a single platform. CrowdOptic's software includes a centralized enterprise management console, as well as various device-side connectors, to give enterprises the ability to deploy a range of wearable computing applications, from livestreaming to context-aware computing. CrowdOptic's middleware for wearables has been implemented in the field service, healthcare, sports & entertainment, and security industries. Customers include the Sacramento Kings, Indiana Pacers, International Speedway Corporation, Philadelphia Eagles, Orlando Magic, San Jose Earthquakes, Sonoma Raceway, Ticketek, Endologix, Protransport-1, Stanford University Medical Center, Nemours Hospital, UCSF, and Carnegie-Mellon.